Barber Daniel
SEC CIK 1742266 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | Pres, CEO, Dir | 652.3K | $88.1K | $1.77M | 18 | 2022-06-08 | 2026-09-15 |
Most active insiders at AQST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barber Daniel | Pres, CEO, Dir | — | $1.77M |
| 2 | Jung Cassie | COO | — | $664.6K |
| 3 | Boyd Peter E. | See Remarks | — | $257.3K |
| 4 | TOTH A ERNEST JR | CFO | — | $242.9K |
| 5 | BRAENDER LORI J | Corp. Sec | — | $167.2K |
| 6 | Kraus Carl N | Chief Medical Off | — | $141.9K |
| 7 | Krop Julie | Dir | — | $125.4K |
| 8 | Korczynski Sherry | Chief Commercial Off | — | $111.3K |
| 9 | Cioffi Melina | SVP, Regulatory Affairs | — | $105.5K |
| 10 | Zalewski Thomas A. | CLO | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-16 14:00 | 2026-09-15 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Pres, CEO, Dir | S - Sale | $4.82 | -25.0K | 652.3K | -4% | -$120.5K |
| D | 2026-09-09 17:10 | 2026-09-08 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Pres, CEO, Dir | X - OptEx | $0.96 | +91.7K | 677.3K | +16% | +$88.1K |
| T | 2026-08-18 16:13 | 2026-08-17 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Pres, CEO, Dir | S - Sale | $4.29 | -25.0K | 585.6K | -4% | -$107.2K |
| MT | 2026-07-17 13:15 | 2026-07-15+ | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Pres, CEO | S - Sale | $4.01 | -25.0K | 610.6K | -4% | -$100.2K |
| T | 2026-06-16 16:09 | 2026-06-15 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Pres, CEO | S - Sale | $4.16 | -25.0K | 635.6K | -4% | -$104.0K |
| T | 2026-05-18 14:03 | 2026-05-15 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Pres, CEO | S - Sale | $4.29 | -8,257 | 660.6K | -1% | -$35.4K |
| 2026-05-07 17:33 | 2026-05-05 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Pres, CEO | F - Tax | $4.18 | -335.9K | 668.8K | -33% | -$1.40M | |
| D | 2026-03-11 | 2026-03-09 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Pres, CEO | A - Grant | $0.00 | +262.0K | 1.19M | +28% | $0 |
| D | 2026-03-11 | 2026-03-10 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Pres, CEO | S - Sale | $4.17 | -180.7K | 1.00M | -15% | -$753.4K |
| 2025-09-29 | 2025-09-26 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Pres, CEO, Dir | S - Sale | $6.03 | -91.3K | 923.4K | -9% | -$550.8K | |
| 2025-09-22 | 2025-09-19 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Pres, CEO, Dir | S - Sale | $6.00 | -400 | 1.01M | -0.0% | -$2,400 | |
| DM | 2025-03-11 | 2025-03-07+ | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Pres, CEO | F - Tax | $2.65 | -83.3K | 1.02M | -8% | -$220.8K |
| D | 2025-03-11 | 2025-03-07 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Pres, CEO | A - Grant | $0.00 | +272.0K | 1.10M | +33% | $0 |
| A | 2024-10-02 | 2024-03-09 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Pres, CEO | F - Tax | $4.88 | -56.8K | 826.5K | -6% | -$277.3K |
| 2024-03-12 | 2024-03-09 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Pres, CEO | F - Tax | $4.88 | -37.9K | 845.4K | -4% | -$185.1K | |
| D | 2024-03-11 | 2024-03-07 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Pres, CEO | A - Grant | $0.00 | +242.6K | 883.3K | +38% | $0 |
| 2023-03-09 | 2023-03-09 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Pres, CEO | A - Grant | $0.00 | +447.0K | 640.7K | +231% | $0 | |
| D | 2022-06-10 | 2022-06-08 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | CEO | P - Purchase | $0.96 | +91.7K | 193.7K | +90% | +$88.1K |
Purchase Sale Sale after option exercise All abbreviations